Make your money go further for just 25p per day

AIM IHT

Novacyt: on these numbers, the cheapest stock on the market

29/01/2021 · Novacyt SA (NCYT) 

AIM AIM Inheritance Tax potential Coronavirus UK

Comments Email Print
Share
Novacyt Versalab image

AIM’s top performer from 2020 announces fabulous numbers, but that was last year, what of the future?

Novacyt (EURONEXT GROWTH: ALNOV; LON: NCYT ), the clinical diagnostics specialist and superstar performer from 2020, updated on trading for the year ending 31 December 2020. Here are the astonishing highlights from an incredible year:


Revenue +2400% to €311.6m (£277.0m) including revenue in the second half of the year of €239.2m (£213.7m).
EBITDA profitability above €210m (£187m), representing an EBITDA margin of more than 67%, after adding 124 people to the payroll.
Cash at 31 December 2020 was…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Novacyt SA

Impressive results | Trading well | Little to cheer

01/05/2025 · Company Insights

News covered here includes our assessment of excellent results from a provider of compliance and e-learning…

A refocused business delivers

30/09/2022 · Company Insights

Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…

More Company Insights

Stunning results | Big dividend payers | Derisory margins

04/06/2025 · Gateley · Gooch & Housego · Premier Miton Group · Ramsdens

Whopping warning!

30/05/2025 · hVIVO

Litigation issues | Modest valuation | Publishing doubts

23/05/2025 · Big Technologies · Bloomsbury Publishing · Impax Asset Management

More on Novacyt SA

Impressive results | Trading well | Little to cheer
A refocused business delivers
Better than expected
Upgrades in the AIM sell-off

More Company Insights

Stunning results | Big dividend payers | Derisory margins
Whopping warning!
Litigation issues | Modest valuation | Publishing doubts

Search for AIM companies qualifying for relief from Inheritance Tax!

Use our unique screening tool to identify Inheritance Tax planning AIM companies

This search will take you to the separate AIMsearch web site which requires a different user name and password to this Investor's Champion site.
Investor’s Champion, making your money go further.

Sign-up to our free email updates

SIGN UP

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Microfact Limited. Microfact Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2025